36C10X24D0028-36C10X26N0165
Delivery Order
Overview
Government Description
Germline Pgx Molecular Testing
Awardee
Awarding / Funding Agency
Place of Performance
Frederick, MD 21703 United States
Pricing
Fixed Price
Set Aside
None
Extent Competed
Full And Open Competition
Est. Average FTE
18
Related Opportunity
(Parent Award)
Fulgent Therapeutics was awarded
Delivery Order 36C10X26N0165 (36C10X-26-N-0165)
for Germline Pgx Molecular Testing
worth up to $6,573,600
by Strategic Acquisition Center Frederick
in September 2026.
The contract
has a duration of 1 year and
was awarded
full & open
with
NAICS 621511 and
PSC Q301
via subject to multiple award fair opportunity acquisition procedures with 1 bid received.
As of today, the Delivery Order has a total reported backlog of $6,567,026 and funded backlog of $6,567,026.
Status
(Open)
Last Modified 10/14/26
Period of Performance
9/30/26
Start Date
9/29/27
Current End Date
9/29/27
Potential End Date
Obligations and Backlog
$6.6K
Total Obligated
$6.6M
Current Award
$6.6M
Potential Award
$6.6M
Funded Backlog
$6.6M
Total Backlog
Award Hierarchy
Indefinite Delivery Contract
Delivery Order
36C10X24D0028-36C10X26N0165
Subcontracts
Activity Timeline
People
Suggested agency contacts for 36C10X24D0028-36C10X26N0165
Competition
Number of Bidders
1
Solicitation Procedures
Subject To Multiple Award Fair Opportunity
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Included (No Subcontracting Possibilities)
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
JVZDRESJLD82
Awardee CAGE
7BRL2
Agency Detail
Awarding Office
36C10X SAC FREDERICK (36C10X)
Funding Office
36C10X
Created By
lashawn.knight@va.gov
Last Modified By
lashawn.knight@va.gov
Approved By
jacky.jean-jacques@va.gov
Legislative
Legislative Mandates
None Applicable
Performance District
MD-06
Senators
Benjamin Cardin
Chris Van Hollen
Chris Van Hollen
Representative
David Trone
Modified: 10/14/26